Results 241 to 250 of about 710,101 (265)

Transdermal Drug Delivery

2009
Transdermal drug delivery is a validated technology contributing significantly to global pharmaceutical care. Since 1980, impressive growth in this field has been observed with many commercial successes; importantly, a new chemical entity was recently developed and approved for transdermal administration without having first been given as an injectable
openaire   +2 more sources

Implantable Drug Delivery

Journal of Biomaterials Applications, 1994
M J, Nitsch, U V, Banakar
openaire   +2 more sources

Cancer epigenetics in clinical practice

Ca-A Cancer Journal for Clinicians, 2023
Veronica Davalos, Manel Esteller
exaly  

Planning for post‐pandemic cancer care delivery: Recovery or opportunity for redesign?

Ca-A Cancer Journal for Clinicians, 2021
Pelin Cinar, Daniela A Bota, Kathryn A Gold   +2 more
exaly  

Treatment of muscle‐invasive and advanced bladder cancer in 2020

Ca-A Cancer Journal for Clinicians, 2020
Vaibhav G Patel, William K Oh, Matthew D Galsky   +2 more
exaly  

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

Ca-A Cancer Journal for Clinicians, 2023
Laura A Huppert, Hope S Rugo
exaly  

Drug Delivery Systems 5B. Oral Drug Delivery

The Journal of Clinical Pharmacology, 1991
openaire   +2 more sources

Liposomal drug delivery

Cancer Treatment Reviews, 1996
Ranson, M, Howell, A, Cheeseman, S, Margison, J   +3 more
openaire   +3 more sources

Equitably improving outcomes for cancer survivors and supporting caregivers: A blueprint for care delivery, research, education, and policy

Ca-A Cancer Journal for Clinicians, 2019
Catherine M Alfano, Corinne R Leach, Tenbroeck G Smith   +2 more
exaly  

Key issues surrounding the health impacts of electronic nicotine delivery systems (ENDS) and other sources of nicotine

Ca-A Cancer Journal for Clinicians, 2017
Zachary Cahn, Alex C Liber, Michal Stoklosa   +2 more
exaly